Last updated on September 2020

Evaluation of the Serum Markers sFLt1 and PlGF for the Prediction of the Complications of the Placental Vascular Pathologies in the 3rd Quarter of the Pregnancy.

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Fetal Growth Retardation | Fetal Death | Eclampsia | Pre-Eclampsia | HELLP Syndrome | Antenatal | Abruptio Placentae
  • Age: Between 18 - 100 Years
  • Gender: Female

Inclusion Criteria:

  • pregnant woman with a diagnosis of placental vascular disease (gestational hypertension, preeclampsia, IUGR)

Exclusion Criteria:

  • patient who refuses the obstetric follow-up

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.